Sangamo Therapeutics Inc (SGMO) — Cash Flow-to-Debt Ratio
Sangamo Therapeutics Inc (SGMO) has a Cash Flow-to-Debt Ratio of -0.35x as of September 2025, meaning its operating cash flow of $-28.50 Million could theoretically repay 0% of its total liabilities ($82.40 Million) in one year. See financial flexibility index of Sangamo Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sangamo Therapeutics Inc Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Sangamo Therapeutics Inc across 26 annual periods. For the full cash flow conversion analysis, see Sangamo Therapeutics Inc (SGMO) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Sangamo Therapeutics Inc (1999–2024)
Year-by-year debt coverage analysis for Sangamo Therapeutics Inc. Check SGMO cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.85x | $-67.14 Million | $78.86 Million | ▲ +68.8% |
| 2023 | -2.73x | $-224.84 Million | $82.43 Million | ▼ -226.3% |
| 2022 | -0.84x | $-223.63 Million | $267.55 Million | ▼ -24.2% |
| 2021 | -0.67x | $-233.25 Million | $346.58 Million | ▼ -274.8% |
| 2020 | 0.39x | $169.88 Million | $441.18 Million | ▲ +154.6% |
| 2019 | -0.71x | $-144.40 Million | $204.78 Million | ▼ -524.9% |
| 2018 | 0.17x | $37.15 Million | $223.88 Million | ▲ +46.7% |
| 2017 | 0.11x | $11.18 Million | $98.84 Million | ▲ +103.7% |
| 2016 | -3.04x | $-65.88 Million | $21.70 Million | ▼ -123.3% |
| 2015 | -1.36x | $-33.72 Million | $24.80 Million | ▼ -776.5% |
| 2014 | -0.16x | $-5.67 Million | $36.58 Million | ▲ +84.8% |
| 2013 | -1.02x | $-19.48 Million | $19.13 Million | ▼ -122.3% |
| 2012 | -0.46x | $-8.08 Million | $17.64 Million | ▲ +87.3% |
| 2011 | -3.59x | $-25.89 Million | $7.20 Million | ▼ -6.5% |
| 2010 | -3.37x | $-23.93 Million | $7.09 Million | ▼ -761.0% |
| 2009 | -0.39x | $-6.14 Million | $15.66 Million | ▲ +71.9% |
| 2008 | -1.39x | $-17.34 Million | $12.45 Million | ▼ -2.1% |
| 2007 | -1.36x | $-16.07 Million | $11.78 Million | ▲ +33.3% |
| 2006 | -2.05x | $-14.48 Million | $7.08 Million | ▼ -461.7% |
| 2005 | -0.36x | $-4.07 Million | $11.17 Million | ▲ +91.6% |
| 2004 | -4.33x | $-10.16 Million | $2.35 Million | ▲ +8.6% |
| 2003 | -4.74x | $-7.44 Million | $1.57 Million | ▲ +3.0% |
| 2002 | -4.88x | $-9.67 Million | $1.98 Million | ▼ -113.3% |
| 2001 | -2.29x | $-6.11 Million | $2.67 Million | ▼ -89.8% |
| 2000 | -1.21x | $-2.45 Million | $2.04 Million | ▲ +34.7% |
| 1999 | -1.85x | $-2.40 Million | $1.30 Million | — |